Scythian Chief Medical Officer Professor Michael Barnes Expands Global Influence as a Cannabis Key Opinion Leader
July 25, 2018 08:34 ET
|
Scythian Biosciences Corp.
TORONTO, July 25, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (to be renamed Sol Global Investments Corp.) (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF)...
Scythian Biosciences Corp. Announces Strategic Partnership for Cannabis in Brazil with one of the Founders of the Country’s Pharma Industry
July 23, 2018 08:34 ET
|
Scythian Biosciences Corp.
TORONTO, July 23, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (to be renamed Sol Global Investments Corp.) (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTC – Nasdaq...
Scythian Announces Strategic Sale of Latin American and Caribbean Assets in $193,000,000 Deal to Aphria
July 17, 2018 08:34 ET
|
Scythian Biosciences Corp.
Sale of Assets Transforms Scythian Into a Highly Liquid and Well Capitalized Company with Over $200 million in Cash and Marketable Securities on Hand Allows for Additional Transactions in Line with...
Scythian Biosciences Announces Positive Pre-Clinical Data on the Safety and Efficacy of Cannabis Derived Combination Therapy for Mild to Moderate Traumatic Brain Injury
July 13, 2018 17:05 ET
|
Scythian Biosciences Corp.
TORONTO, July 13, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) and its partners at the University of Miami...
Scythian Biosciences Corp Announces Colcanna SAS as one of the Industry’s First to Receive Key Cannabis Licences for the Cultivation, Extraction, Production and Research of Medical Cannabis for the Colombian Local Market and Export to International Markets
July 09, 2018 08:30 ET
|
Scythian Biosciences Corp.
TORONTO, July 09, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that Colombian-based...
Scythian Biosciences Announces Name Change to SOL Global Investments Corp.
June 05, 2018 08:58 ET
|
Scythian Biosciences Corp.
TORONTO, June 05, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that the Company will...
Scythian Biosciences Announces ColCanna SAS’ Receipt of Licence to Cultivate and Import CBD into Colombia
May 16, 2018 09:14 ET
|
Scythian Biosciences Corp.
– ENTERS INTO EXCLUSIVE SUPPLY AGREEMENT WITH APHRIA – – COLCANNA TO BE FIRST TO MARKET WITH APHRIA’S PHARMACEUTICAL GRADE CBD OIL IN COLOMBIA – TORONTO, May 16, 2018 (GLOBE NEWSWIRE) -- Scythian...
Scythian Biosciences Announces Binding Agreement for Argentinian Acquisition of ABP
May 11, 2018 08:30 ET
|
Scythian Biosciences Corp.
– ABP HOLDS FIRST & ONLY CANNABIS LICENSE IN ARGENTINA – – ABP REVENUES IN EXCESS OF USD$11 MILLION IN 2017 AND PROFITABLE – TORONTO, May 11, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences...
Scythian Biosciences Announces Licensing Agreement With Isodiol International Inc.
May 07, 2018 08:30 ET
|
Scythian Biosciences Corp.
— Scythian Makes $2 Million Investment Alongside Serruya Private Equity, and the Delavaco Group — — Isodiol Recently Awarded the Highly Coveted UK Government Approval for Natural CBD Isolate as an...
Scythian Announces Marigold’s Exclusive Agreement with Jamaica’s Peter Tosh Museum
May 03, 2018 08:30 ET
|
Scythian Biosciences Corp.
— Medicinal Cannabis Dispensary to open in Peter Tosh Square — — Peter Tosh Square to be the home of Marigold’s first herb house — TORONTO, May 03, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences...